Results 21 to 30 of about 2,229 (127)

Autoantibodies Against the Immunodominant Bullous Pemphigoid Epitopes Are Rare in Patients With Dermatitis Herpetiformis and Coeliac Disease

Frontiers in Immunology, 2020
Dermatitis herpetiformis (DH) is an extraintestinal manifestation of coeliac disease (CD). Patients with DH have an elevated risk of development of another autoimmune blistering skin disease, bullous pemphigoid (BP). In this study we investigated whether
Antti Nätynki, Jussi Tuusa, Kaisa Hervonen, Kaisa Hervonen, Katri Kaukinen, Katri Kaukinen, Outi Lindgren, Outi Lindgren, Laura Huilaja, Nina Kokkonen, Teea Salmi, Teea Salmi, Kaisa Tasanen   +12 more
doaj   +1 more source

A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV Inhibitors

Frontiers in Immunology, 2019
Background: Anti-hyperglycemic drug dipeptidyl peptidase-IV inhibitors (DPP-4i) have recently been recognized as bullous pemphigoid (BP) inducing drugs. It remains uncertain whether DPP-4i induce BP-IgG autoantibodies before the onset of BP.Objective: To
Kentaro Izumi, Wataru Nishie, Mutsuo Beniko, Hiroshi Shimizu   +3 more
doaj   +1 more source

Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis

Frontiers in Medicine, 2022
BackgroundBullous pemphigoid (BP) is the most common autoimmune-blistering disease, clinically characterized by erythematous urticarial plaques, blisters, and intense pruritus, induced by autoantibodies against two proteins of the dermo-epidermal ...
Francesco Moro, Francesco Moro, Feliciana Mariotti, Anna Pira, Naomi De Luca, Biagio Didona, Gianluca Pagnanelli, Giovanni Di Zenzo   +7 more
doaj   +1 more source

Dipeptidyl peptidase IV inhibitor-associated bullous pemphigoid: a recently recognized autoimmune blistering disease with unique clinical, immunological and genetic characteristics

Immunological Medicine, 2019
Bullous pemphigoid (BP) is an organ-specific autoantibody-mediated autoimmune blistering skin disorder that tends to affect the elderly. Tense blister formation associated with itchy urticarial erythema is clinically observed in BP, and subepidermal ...
Wataru Nishie
doaj   +1 more source

Human eosinophils express the high affinity IgE receptor, FcεRI, in bullous pemphigoid.

PLoS ONE, 2014
Bullous pemphigoid (BP) is an autoimmune blistering disease mediated by autoantibodies targeting BP180 (type XVII collagen). Patient sera and tissues typically have IgG and IgE autoantibodies and elevated eosinophil numbers. Although the pathogenicity of
Kelly N Messingham, Heather M Holahan, Alexandra S Frydman, Colleen Fullenkamp, Rupasree Srikantha, Janet A Fairley   +5 more
doaj   +1 more source

Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid

Antibodies, 2022
Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease predominantly affecting elderly patients and carries significant morbidity and mortality.
Connor Cole, Luca Borradori, Kyle T. Amber   +2 more
doaj   +1 more source

Case Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review

Frontiers in Immunology, 2023
Linear IgA/IgG bullous dermatosis (LAGBD) is a rare autoimmune subepidermal bullous disorder characterized by linear deposition of concurrent IgA and IgG autoantibodies along the basement membrane zone (BMZ). The clinical features of LAGBD can be diverse,
Yuxi Zhou, Xingli Zhou, Xun Feng, Dengmei Xia, Hua Qian, Hongjie Liu, Xiaoguang Li, Wei Li   +7 more
doaj   +1 more source

Case Report: The many faces of bullous pemphigoid

Frontiers in Immunology, 2023
The pemphigoid group comprises a number of bullous skin diseases with autoantibodies against different constituents of the basement membrane zone that result in subepidermal detachment and clinically characteristic tense blisters, erosions, urticarial ...
Laura Rechtien, Laura Rechtien, Lukas Sollfrank, Lukas Sollfrank, Yannick Foerster, Yannick Foerster, Carola Berking, Carola Berking, Michael Sticherling, Michael Sticherling   +9 more
doaj   +1 more source

Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases

Frontiers in Immunology, 2023
IntroductionWe describe a series of patients whose auto-immune bullous skin disease (AIBD) of the dermal-epidermal junction (DEJ) was characterized by clinical, immunological and ultrastructural features intermediate between bullous pemphigoid (BP) and ...
Raphaël Janela, Norito Ishii, Marion Castel, Fabienne Jouen, Lucie Cellier, Philippe Courville, Pascal Joly, Pascal Joly, Vivien Hébert, Vivien Hébert   +9 more
doaj   +1 more source

Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association?

Frontiers in Immunology, 2022
Bullous pemphigoid (BP) represents the most common autoimmune bullous disease and is characterized by IgG autoantibodies targeting collagen XVII (BP180). BP has reportedly been occurred in association with other inflammatory skin diseases.
Roberto Maglie, Maria Efenesia Baffa, Francesca Montefusco, Carlo Pipitò, Stefano Senatore, Marco Capassoni, Marco Capassoni, Vincenza Maio, Marco Matucci Cerinic, Marco Matucci Cerinic, Emiliano Antiga, Serena Guiducci, Serena Guiducci   +12 more
doaj   +1 more source